Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
326030:KRX
SK Biopharmaceuticals Co Ltd
₩102,300.00
-0.68%
(-700.00) 1D
Apr 24, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 326030...
Open
₩102,700
High
₩102,900
Low
₩101,600
Mkt. cap
8.01T
Avg. vol.
556.58K
Volume
131.05K
P/E ratio
30.01
52-wk high
₩144,100
52-wk low
₩86,900
EPS
₩3,409
Shares outstanding
78.31M
No. of employees
265
News stories
From sources across the web
About SK Biopharmaceuticals Co Ltd
CEO-
Employees265
Founded1993
Headquarters-
SectorPharmaceutical industry
Websiteskbp.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
144.38B
176.28B
191.73B
194.36B
Cost of goods sold
10.50B
9.90B
7.55B
14.95B
Cost of revenue
10.50B
9.90B
7.55B
14.95B
Research and development expenses
42.00B
39.56B
40.93B
51.85B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60.78B
60.40B
68.98B
77.42B
Operating expense
108.21B
104.49B
114.07B
133.13B
Total operating expenses
118.71B
114.39B
121.62B
148.08B
Operating income
25.67B
61.88B
70.11B
46.28B
Other non operating income
-548.82M
6.70B
-8.46B
-7.51B
EBT including unusual items
20.34B
34.68B
62.11B
33.76B
EBT excluding unusual items
20.49B
34.82B
61.27B
36.66B
Income tax expense
714.08M
5.15B
-9.26B
-98.98B
Effective tax rate
3.51%
14.86%
-14.90%
-293.19%
Other operating expenses
1.99B
1.34B
1.37B
1.11B
Net income
23.30B
32.92B
74.14B
136.59B
Net profit margin
16.14%
18.67%
38.67%
70.28%
Earnings per share
-
-
-
-
Interest and investment income
1.70B
1.79B
1.88B
1.72B
Interest expense
-2.54B
-2.13B
-1.70B
-1.32B
Net interest expenses
-844.42M
-337.99M
179.24M
397.10M
Depreciation and amortization charges
1.97B
1.97B
2.23B
2.18B
EBITDA
30.30B
66.24B
74.11B
50.23B
Gain or loss from assets sale
4.00K
8.25M
10.55M
176.00M
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more